Business description: Grifols, S.A.

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:

- products derived from plasma (85.2%): products for use by the pharmaceutical and biotechnology industries;

- diagnostic machines and reagents (8.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;

- hospital products (3%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;

- other (2.9%): primarily intermediate biological products and subcontracted manufacturing services.

Net sales are distributed geographically as follows: Spain (5.9%), European Union (15.5%), the United States and Canada (56.7%) and other (21.9%).

Number of employees: 23,800

Sales by Activity: Grifols, S.A.

Fiscal Period: December20202021202220232024

Biopharma

4.24B 3.81B 5.01B 5.56B 6.14B

Bio Supplies

224M 226M 146M 160M 216M

Diagnostic

776M 779M 671M 670M 645M

Others

31.99M 39.62M 250M 203M 209M

Intersegments

-53.11M -67.55M -8.95M - -

Hospital

119M 141M - - -
See all business segments

Geographical breakdown of sales: Grifols, S.A.

Fiscal Period: December20202021202220232024

United States + Canada

3.6B 3.15B 3.86B 3.9B 4.09B

Rest of the World

906M 872M 1.18B 1.44B 1.58B

Rest of European Union

495M 544M 712M 893M 1.12B

Spain

339M 362M 321M 363M 423M
See all geographic segments

Executive Committee: Grifols, S.A.

Manager TitleAgeSince
Chief Executive Officer 56 31/03/2024
Chief Tech/Sci/R&D Officer 51 31/08/2024
Director of Finance/CFO 62 31/12/1995
Comptroller/Controller/Auditor 46 31/12/2015
Corporate Officer/Principal 61 30/06/2018
See GRIFOLS, S.A. governance

Composition of the Board of Directors: Grifols, S.A.

Director TitleAgeSince
Director/Board Member 69 12/04/2000
Director/Board Member 62 23/05/2015
Director/Board Member 49 29/05/2016
Director/Board Member 60 23/05/2019
Director/Board Member 57 09/06/2022
Director/Board Member 48 09/06/2022
Director/Board Member 47 18/12/2023
Director/Board Member 60 28/05/2015
Director/Board Member 56 25/02/2024
Chairman 61 04/06/2025
Composition of the Board of Directors

Shareholders: Grifols, S.A.

NameEquities%Valuation
9.195 %
39,183,692 9.195 % 476 M €
Scranton Enterprises BV
8.404 %
35,812,622 8.404 % 435 M €
7.089 %
30,209,093 7.089 % 367 M €
Ralledor Holding Spain SL
6.154 %
26,224,374 6.154 % 319 M €
Capital Research & Management Co. (World Investors)
3.405 %
14,511,687 3.405 % 176 M €
NameEquities%Valuation
Brandes Investment Partners LP
7.177 %
18,761,824 7.177 % 168 M €
Cobas Asset Management SGIIC SA
1.454 %
3,801,931 1.454 % 34 M €
AzValor Asset Management SGIIC SA
0.5785 %
1,512,423 0.5785 % 14 M €
SIA Funds AG
0.5068 %
1,324,947 0.5068 % 12 M €
GVC Gaesco Gestión SGIIC SA
0.2395 %
626,097 0.2395 % 6 M €
NameEquities%Valuation
Brandes Investment Partners LP
9.847 %
25,741,348 9.847 % 233 M €
Capital Research & Management Co. (World Investors)
8.233 %
21,522,236 8.233 % 195 M €
Permian Investment Partners LP
6.916 %
18,081,321 6.916 % 163 M €
Black Creek Investment Management, Inc.
4.855 %
12,690,887 4.855 % 115 M €
Armistice Capital LLC
3.549 %
9,278,000 3.549 % 84 M €
NameEquities%Valuation
Yousif Capital Management LLC
0.001549 %
13,202 0.001549 % 80 202 €
List of GRIFOLS, S.A. shareholders

Holdings: Grifols, S.A.

NameEquities%Valuation
437,069,656 6.49% 419,044,903 $

Company details: Grifols, S.A.

Grifols SA

Avinguda de la Generalitat, 152-158 Parc de Negocis Can Sant Joan

08174, Barcelona

+34 935 712 200

http://www.grifols.com
address Grifols, S.A.(GRF)

Group companies: Grifols, S.A.

NameCategory and Sector
Financial Conglomerates
Grifols India Healthcare Pvt Ltd.
Multi-Line Insurance
See all subsidiaries

Biopharmaceuticals

Change 5d. change 1-year change 3-years change Capi.($)
+2.96%+4.35%+20.13%-36.34% 7.7B
-0.98%+1.53%-18.45%-15.47% 77.69B
+1.79%+2.40%-47.94%-11.88% 57.88B
-1.55%+2.12%+26.15%+23.99% 52.56B
+0.12%+1.89%+19.12%+100.12% 37.85B
+3.33%+3.38%-41.04%-38.55% 19.7B
-0.67%+3.15%+116.40%+122.28% 17.93B
+0.48%+12.63%+50.18%+694.31% 16.32B
-0.04%-.--%+84.28%+129.06% 14.02B
+0.59%-1.54%+16.33%-15.92% 13.1B
Average +0.01%+2.57%+22.52%+95.16% 31.48B
Weighted average by Cap. -0.32%+2.45%+4.89%+54.80%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
10.80EUR
Average target price
15.96EUR
Spread / Average Target
+47.76%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GRF Stock
  4. Company Grifols, S.A.